# Dr. Reddy's Laboratories Ltd. (NYSE: RDY), Medchal-Malkajgiri District, India – FDA Inspections

Source: https://www.keypedia.com/companies/dr-reddys-laboratories-ltd/5a4c4806-5444-4838-9cda-0b0da2f42221

> Inspection records and compliance data for Dr. Reddy's Laboratories Ltd. in Medchal-Malkajgiri District. 9 FDA inspections on record, 4 Form 483s, last inspected August 14, 2026. Publicly traded as NYSE: RDY.

---

## Details

- Name: Dr. Reddy's Laboratories Ltd.
- FEI Number: 3002949099
- Facility Type: Drug Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: Survey No. 41, 42 Part, 45 Part & 46 Part,Bachupally Village And Mandal
- City: Medchal-Malkajgiri District
- Country Name: India
- Address: Survey No. 41, 42 Part, 45 Part & 46 Part,Bachupally Village And Mandal, Medchal-Malkajgiri District, India
- Country: India

## Stock

- Stock ticker: RDY
- Exchange: NYSE
- Share price: $14.73
- Market cap: $12.3B
- Price as of: November 13, 2026

## Related Documents

- [483 - Dr. Reddy's Laboratories Ltd. - 2026-08-14](https://www.keypedia.com/records/483/dr-reddys-laboratories-ltd/272efcfa-30b9-49a8-b265-3888dd523c43) — source: FDA, date: August 14, 2026
- [FDA Inspection 1330894 - Dr. Reddy's Laboratories Ltd. - 2026-08-14](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-ltd/e4989a31-ee5c-4e9b-a585-77e17387449e) — source: FDA, date: August 14, 2026
- [483 - Dr. Reddy's Laboratories Ltd. - 2023-10-27](https://www.keypedia.com/records/483/dr-reddys-laboratories-ltd/383e5e95-1e2b-441b-99ea-82d2c5b02062) — source: FDA, date: October 27, 2023
- [FDA Inspection 1222556 - Dr. Reddy's Laboratories Ltd. - 2023-10-27](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-ltd/18ff5b36-8545-4cb9-a106-1c4afee1be15) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 27, 2023
- FDA Inspection 1121029 - Dr. Reddy's Laboratories Ltd. - 2020-02-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2020
- [483 - Dr. Reddy's Laboratories Ltd. - 2020-02-24](https://www.keypedia.com/records/483/dr-reddys-laboratories-ltd/1173293b-92c2-497b-8e97-a5a6507a2efe) — source: FDA, date: February 24, 2020
- [483 - Dr. Reddy's Laboratories Ltd. - 2019-02-08](https://www.keypedia.com/records/483/dr-reddys-laboratories-ltd/6998775b-5dcf-4606-bebe-b11033525465) — source: FDA, date: February 8, 2019
- [FDA Inspection 1079024 - Dr. Reddy's Laboratories Ltd. - 2019-02-08](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-ltd/785516b7-8092-4bc8-841f-e846a54780ad) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 8, 2019
- [483 - Dr. Reddy's Laboratories Ltd. - 2017-04-28](https://www.keypedia.com/records/483/dr-reddys-laboratories-ltd/5cf54d6c-e53a-432a-b758-d78d80419fa9) — source: FDA, date: April 28, 2017
- [FDA Inspection 1010046 - Dr. Reddy's Laboratories Ltd. - 2017-04-28](https://www.keypedia.com/records/fda_inspections/dr-reddys-laboratories-ltd/7efabdb1-3e4e-4d64-ae8e-6bca9c800491) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2017
- FDA Inspection 940784 - Dr. Reddy's Laboratories Ltd. - 2015-06-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 17, 2015
- FDA Inspection 836270 - Dr. Reddy's Laboratories Ltd. - 2013-04-25 — classification: No Action Indicated (NAI), source: FDA, date: April 25, 2013
- FDA Inspection 755298 - Dr. Reddy's Laboratories Ltd. - 2011-11-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 24, 2011
- FDA Inspection 632969 - Dr. Reddy's Laboratories Ltd. - 2009-11-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 13, 2009

## Related Companies

- [Strides Pharma Science Limited](https://www.keypedia.com/companies/strides-pharma-science-limited/fbdc3ce9-e3c5-4667-86ce-77b376a00100)
- [Dr Reddy's Laboratories Limited](https://www.keypedia.com/companies/dr-reddys-laboratories-limited/97f3d461-62f0-4198-9e9d-7f7c7d43af86)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/185c125c-128f-47be-ab1b-e1d5324bcc21)
- [Mankind Pharma Limited](https://www.keypedia.com/companies/mankind-pharma-limited/448ddf49-4ff4-4a2b-8444-e8cc23677777)
- [Centaur Pharmaceuticals Private Ltd.](https://www.keypedia.com/companies/centaur-pharmaceuticals-private-ltd/65d235da-0400-49d7-acff-38fe013fc5b4)
- [PharmaGend Global Medical Services Pte. Ltd.](https://www.keypedia.com/companies/pharmagend-global-medical-services-pte-ltd/a4dcdf70-101c-46bc-94ab-ddb8956f44a4)
- [I 3 PHARMACEUTICALS, LLC](https://www.keypedia.com/companies/i-3-pharmaceuticals-llc/020702e4-1539-47b8-87d9-725035cecbfe)
- [Intas Pharmaceuticals Limited](https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8)
- [Strides Pharma, Inc.](https://www.keypedia.com/companies/strides-pharma-inc/e9e4da51-c260-486c-8969-86d64b9b36af)
- [Actavis Laboratories FL, Inc.](https://www.keypedia.com/companies/actavis-laboratories-fl-inc/6c959344-9e81-4c3c-9e6d-580e25151c7d)

## Related Officers

- [Cheryl A. Clausen](https://www.keypedia.com/people/cheryl-a-clausen/2306b2bc-8f01-4f77-ba2d-1a3186d6f6fc)
- [Angela Glenn](https://www.keypedia.com/people/angela-glenn/5ba5e1e2-883b-42c4-aae0-3564820723e8)
- [Advisor](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)
